People
Todd Sone
aMoon general partner and Scipher Medicine board director. Previously invested at Signet Healthcare Partners and Joddes and researched pharmaceutical equities at Morgan Stanley and Goldman Sachs. Todd Sone is published by aMoon as General Partner. Healthcare investor with experience in equity research and institutional investing; co-leads the Growth strategy. Todd Sone is a current Iantrek board member and is identified by the company as aMoon general partner. The issuer2025SeriesC announcement names aMoon as joining the round, without formally assigning co-lead status.
Roles
Scipher Medicine
CurrentBoard Director
aMoon
CurrentGeneral Partner
Iantrek, Inc.
CurrentBoard Member